Position in UTHR
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$376,438,017
+$83,020,453 QoQ
Shares Held
694,753
+15.4% QoQ
Ownership
1.62%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#10
of 870 holders
Holding Since
Mar 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in UTHR Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026NORGES BANK holds $2,351,821,288 across 19 Drug Manufacturers - Specialty & Generic names. UTHR ranks #2 (16.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TEVA |
Teva Pharmaceutical Industries Ltd
|
32,299,753 | $1,094,315,631 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
This page
|
694,753 | $376,438,017 | |
| 3 | ZTS |
Zoetis Inc.
|
4,689,847 | $337,012,405 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
973,880 | $164,137,735 | |
| 5 | ALKS |
Alkermes plc.
|
2,156,814 | $113,017,053 | |
| 6 | HLN |
Haleon plc
|
7,175,000 | $66,942,750 | |
| 7 | LNTH |
Lantheus Holdings, Inc.
|
586,845 | $65,104,584 | |
| 8 | VTRS |
Viatris Inc
|
3,822,744 | $60,705,174 |
All Filings in UTHR
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $376,438,017 | 694,753 | Shares | Sole | 2026-08-12 | |
| 2025-12-31 | $293,417,564 | 602,191 | Shares | Sole | 2026-02-10 | |
| 2025-06-30 | $136,453,319 | 474,868 | Shares | Sole | 2025-08-13 | |
| 2024-12-31 | $151,764,246 | 430,122 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $151,808,527 | 423,632 | Shares | Sole | 2025-11-12 | |
| 2024-06-30 | $12,401,470 | 38,931 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $106,713,439 | 464,537 | Shares | Sole | 2025-05-14 | |
| 2023-12-31 | $100,518,755 | 457,132 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $98,924,058 | 437,969 | Shares | Sole | 2024-11-13 | |
| 2023-06-30 | $89,365,560 | 404,827 | Shares | Sole | 2024-08-14 | |
| 2023-03-31 | $88,714,139 | 396,116 | Shares | Sole | 2024-05-15 | |
| 2022-12-31 | $124,157,729 | 446,466 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $87,903,377 | 419,827 | Shares | Sole | 2023-11-13 | |
| 2022-06-30 | $96,060,531 | 407,658 | Shares | Sole | 2023-08-14 | |
| 2022-03-31 | $74,667,750 | 416,185 | Shares | Sole | 2023-05-12 | |
| 2021-12-31 | $93,324,952 | 431,900 | Shares | Sole | 2022-03-09 | |
| 2021-09-30 | $76,698,711 | 415,531 | Shares | Sole | 2022-11-14 | |
| 2021-06-30 | $75,590,815 | 421,330 | Shares | Sole | 2022-08-15 | |
| 2021-03-31 | $79,969,779 | 478,088 | Shares | Sole | 2022-05-09 | |
| 2020-12-31 | $58,944,003 | 388,326 | Shares | Sole | 2021-03-02 | |
| 2020-09-30 | $40,855,106 | 404,506 | Shares | Sole | 2021-11-12 | |
| 2020-06-30 | $53,111,498 | 438,938 | Shares | Sole | 2021-08-13 | |
| 2020-03-31 | $50,051,274 | 527,800 | Shares | Sole | 2021-05-07 | |
| No filing history on record for this holder in this stock. | ||||||